Company / Free Cash Flow
Kiniksa Pharmaceuticals International, plc Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$136.4M
FY2025
5-year range
-$161.6M / $136.4M
FY2021-FY2025
Trend
+436.8%
vs FY2024
Sector context
#42 of 194
Health Care
What the data says
Free Cash Flow changed +437% YoY in FY2025, a notable deviation from the 8-year average annual change of +75%.
Based on SEC 10-K filings.
$136M in FY2025 with a 3-year CAGR of +188.1%. Top quartile in the Health Care sector.
Improved from $13M to $136M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +188.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 194This company $136.4M Sector average $470.8M
▼
-71.0% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's free cash flow has grown for 4 consecutive years.
- 3-year CAGR of +188.1%, indicating consistent growth.
- In FY2025, free cash flow increased 436.8% year-over-year.
- Ranks #42 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $136.4M | +436.8% |
| FY2024 | $25.4M | +92.9% |
| FY2023 | $13.2M | +131.0% |
| FY2022 | $5.7M | +103.5% |
| FY2021 | -$161.6M | -18.1% |
| FY2020 | -$136.8M | +15.3% |
| FY2019 | -$161.6M | -87.2% |
| FY2018 | -$86.3M | -71.6% |
| FY2017 | -$50.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026